Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Acutus Medical Inc (NQ: AFIB )

0.1701 +0.0063 (+3.85%)
Streaming Delayed Price Updated: 3:37 PM EDT, Apr 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Acutus Medical Inc

< Previous 1 2 3 Next >
Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical to Cancel Third Quarter 2023 Conference Call
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Reports Third Quarter 2023 Financial Results
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Strategic Realignment of Resources and Corporate Restructuring
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical to Announce Third Quarter 2023 Financial Results
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Reports Second Quarter 2023 Financial Results
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical to Present at the 43rd Annual Canaccord Growth Conference
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical to Announce Second Quarter 2023 Financial Results
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical to Showcase Innovative Cardiac Mapping and Ablation Technologies at HRS 2023
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Reports First Quarter 2023 Financial Results
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical to Announce First Quarter 2023 Financial Results
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Preliminary Unaudited First Quarter 2023 Results
From Acutus Medical, Inc.
Via GlobeNewswire
RECOVER AF Study Reports 91% of First Redo Patients Achieved Freedom from AF at One Year After AcQMap-guided Ablation Therapy
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Reports Fourth Quarter and Full Year 2022 Financial Results
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical to Announce Fourth Quarter and Full Year 2022 Financial Results
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
Late-Breaking ACQFORCE FLUTTER Trial Meets Primary Endpoint for Safety and Efficacy with the First Gold-Tipped Contact Force Sensing Ablation Catheter
The AcQBlate Force Sensing Ablation Catheter and System demonstrated 94% acute success with no serious adverse events and significantly less ablation time 
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Results and Appointment of Chief Financial Officer
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation during the Late-Breaking Clinical Trials and First Report Investigations sessions at the 2023 AF Symposium
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Achieves EU MDR Submission Milestone in Sale of Left-Heart Access Portfolio to Medtronic
From Acutus Medical, Inc.
Via GlobeNewswire
Acutus Medical Announces Full Market Release of next generation software platform AcQMap 8.5
Software improvements further leverage the system’s unique ultrasound capabilities for non-contact anatomy reconstruction 
From Acutus Medical, Inc.
Via GlobeNewswire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.